Joe Payne, the CEO of Arcturus Therapeutics, is back to talk about exciting progress on their messenger RNA Covid-19 vaccine and answer questions about testing for antibodies versus T-cell immunity, potential longevity and timing of the vaccine, and what countries are signing up for the potential Arcturus solution. He also talks about what we might expect after the pandemic slows and how Covid-19 might be similar to or differ from the seasonal influenza, and how public education will be key. Another must-listen episode to stay current.

The Arcturus website:
https://arcturusrx.com/

The UCSF Grand Rounds talk we mention:
https://www.youtube.com/watch?v=kNADw5io9Ms

The first episode with Joe from April 2020:
https://www.podomatic.com/podcasts/deardiscreetguide/episodes/2020-04-26T05_00_00-07_00

Thoughts? Comments? Potshots? Contact the show at:
https://www.discreetguide.com/

Follow or like us on podomatic.com (it raises our visibility :)
https://www.podomatic.com/podcasts/deardiscreetguide

Support us on Patreon:
https://www.patreon.com/discreetguide

Follow the host on Twitter:
@DiscreetGuide

The host on LinkedIn:
https://www.linkedin.com/in/jenniferkcrittenden/